The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 |
|---|---|
| Cash and cash equivalents at beginning of period | 0 |
| Net income | 342,819 |
| Payment of operation costs through promissory note | -47,545 |
| Interest earned on marketable securities held in trust account | 1,727,160 |
| Prepaid expenses | 14,191 |
| Prepaid insurance | 119,167 |
| Accrued expenses | 39,942 |
| Net cash used in operating activities | -1,430,212 |
| Investment of cash into trust account | 253,000,000 |
| Net cash used in investing activities | -253,000,000 |
| Proceeds from sale of units, net of underwriting discounts paid | -248,600,000 |
| Proceeds from sale of private placements warrants | 6,400,000 |
| Repayment of promissory note - related party | 248,243 |
| Advisory fee payable - non-current | -1,204,500 |
| Payment of offering costs | 381,212 |
| Net cash provided by financing activities | 255,575,045 |
| Net change in cash and cash equivalents | 1,144,833 |
| Cash and cash equivalents at end of period | 1,144,833 |
HCM III ACQUISITION CORP. (HCMAW)
HCM III ACQUISITION CORP. (HCMAW)